Trial Profile
Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2023
Price :
$35
*
At a glance
- Drugs Triamcinolone (Primary)
- Indications Allergic asthma; Allergic rhinitis
- Focus Therapeutic Use
- Acronyms NACHO
- 01 Nov 2023 Results (n=20) assessing Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids published in the Clinical and Experimental Allergy
- 01 Aug 2018 Status changed from not yet recruiting to recruiting.
- 16 Feb 2018 New trial record